Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
CRVS

Corvus Pharmaceuticals (CRVS) stock: insider trades, news & valuation

Net buying
Close · Oct 9, 2026 $10.52 +3.0% on the day +45.1% over 12 months 52-week range $6.50 – $25.52

Share price and insider trades

CRVS closeInsider buyInsider sale
0102030NovDecJan 2026FebMarAprMayJunJulAugSepOctBought $83,453 on 2026-05-18 · Richard A Md MillerBought $250,201 on 2026-06-11 · David Scott Moore
Bought, 12 months$334K
Sold, 12 months$0
Insiders buying2
Insiders selling0

Corvus Pharmaceuticals insider trading at a glance (Oct 9, 2026): in the past 12 months, 2 insiders bought $334K and 0 sold $0 of CRVS stock on the open market.

CRVS insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q2 2026: $334K bought (3 trades)$334KQ2 2026Q3 2026Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0—0
Q3 2026—0—0
Q2 2026$334K3—0

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.3×Last 5 sessions
Insiders' paper profit−$32KOn all tracked purchases -9.7%

Summary

Over the past 12 months, 2 Corvus Pharmaceuticals, Inc. insiders reported open-market purchases totaling $334K, while 0 insiders reported sales totaling $0.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Jun 15SEC David Scott MooreDirector Buy 21,700new position $11.53 $250K -8.8% —
May 20SEC Richard A Md MillerCEO, President Buy 5,0001,193,103 held (+0%) $12.05 $60K -12.7% —
May 20SEC Richard A Md MillerCEO, President Buy 1,9321,195,035 held (+0%) $12.01 $23K -12.4% —

Insiders at Corvus Pharmaceuticals, Inc.

InsiderBoughtSoldLast filingScore
David Scott MooreDirector $250K — Jun 15, 2026 —
Richard A Md MillerCEO, President $83K — May 20, 2026 —

CRVS stock: common questions

Are Corvus Pharmaceuticals, Inc. insiders buying CRVS stock?

In the past 12 months, 2 insiders reported open-market purchases of CRVS worth $334K. The latest was Director David Scott Moore bought $250K of CRVS at $11.53 — first open-market purchase in our records; opens a new position.

Are Corvus Pharmaceuticals, Inc. insiders selling CRVS stock?

0 insiders reported sales worth $0 over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is CRVS's 52-week range?

Over the past year CRVS has traded between $6.50 and $25.52. It last closed at $10.52 on Oct 9, 2026.